Eye drop for treating myopia

Abstract

The invention discloses an eye drop for treating myopia. The eye drop comprises the following components in parts by weight: 4-7 parts of flos chrysanthemi indici, 3.5-3.9 parts of honeysuckle, 9-10 parts of cuscuta chinensis, 3-3.9 parts of oleum menthae, 6-9.8 parts of silver ion solution, and 4-8.9 parts of mulberry silk fiber. The eye drop can alleviate asthenopia.

Description

technical field [0001] The invention relates to an eye drop, in particular to an eye drop for treating myopia. Background technique [0002] Existing eye drops just relieve eyesight fatigue, but do not have the effect of treatment and health care. Contents of the invention [0003] Purpose of the invention: In order to solve the deficiencies in the prior art, the present invention provides an eye drop for treating myopia. [0004] Technical solution: an eye drop for treating myopia, which is composed of the following components in parts by weight: 4-7 parts of wild chrysanthemum, 3.5-3.9 parts of honeysuckle, 9-10 parts of dodder, 3-3.9 parts of peppermint oil, silver 6-9.8 parts of ion solution, 4-8.9 parts of mulberry silk fiber. [0005] Preferably, the eye drops are composed of the following components in parts by weight: 5 parts of wild chrysanthemum, 3.7 parts of honeysuckle, 9.5 parts of dodder, 3.5 parts of peppermint oil, 7.3 parts of silver ion solution, and 6 ...

AI Technical Summary

Problems solved by technology

[0002] Existing eye drops only relieve visual fatigue, but do not have the effect of treatment and health care